If your primary concern involves gastritis, leaky gut, intestinal inflammation, or other digestive issues, oral BPC-157 makes theoretical sense and receives the most favorable user reports
Moreover, BPC 157 exhibits cytoprotective properties, meaning it can shield cells from damage induced by harmful agents such as toxins or oxidative stress
The most commonly reported side effects are mild to moderate gastrointestinal symptoms such as nausea, constipation, and indigestion, and they usually ease as your body adjusts
I appreciate the unique perspective you bring to every topic you cover
Similarly, outcomes were consistent when comparing patients who used both GLP-1 RAs and SGLT2 is with those who did not receive either medication within the first 3 months post-transplant (Supplemental Table 10)